GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sequent Scientific Ltd (NSE:SEQUENT) » Definitions » Revenue

Sequent Scientific (NSE:SEQUENT) Revenue : ₹15,074 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sequent Scientific Revenue?

Sequent Scientific's revenue for the three months ended in Dec. 2024 was ₹3,908 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was ₹15,074 Mil. Sequent Scientific's Revenue per Share for the three months ended in Dec. 2024 was ₹14.77. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₹58.47.

During the past 12 months, the average Revenue per Share Growth Rate of Sequent Scientific was 6.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 0.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Sequent Scientific's highest 3-Year average Revenue per Share Growth Rate was 25.90% per year. The lowest was -2.60% per year. And the median was 6.20% per year.


Sequent Scientific Revenue Historical Data

The historical data trend for Sequent Scientific's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequent Scientific Revenue Chart

Sequent Scientific Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,605.13 13,520.35 14,101.72 14,182.75 13,663.00

Sequent Scientific Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,293.60 3,577.70 3,902.10 3,686.50 3,908.10

Competitive Comparison of Sequent Scientific's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Sequent Scientific's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sequent Scientific's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sequent Scientific's Revenue distribution charts can be found below:

* The bar in red indicates where Sequent Scientific's Revenue falls into.


;
;

Sequent Scientific Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹15,074 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sequent Scientific  (NSE:SEQUENT) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Sequent Scientific Revenue Related Terms

Thank you for viewing the detailed overview of Sequent Scientific's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sequent Scientific Business Description

Traded in Other Exchanges
Address
Plot No. E7, Road No. 22, 301, 3rd Floor, Dosti Pinnacle, Wagle Industrial Estate, Thane (West), Mumbai, MH, IND, 400 604
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.

Sequent Scientific Headlines

No Headlines